Calcium-based antacids in GW 0-33 |
|
|
|
|
|
No use |
6,964 |
171 |
(2.5) |
Reference |
Reference |
Any use |
1,863 |
60 |
(3.2) |
1.3 (1.0-1.7) |
1.2
(0.9-1.6) |
Low dose (<1 g/day) |
959 |
31 |
(3.2) |
1.3 (0.9-1.9) |
1.3
(0.9-1.8) |
High dose (≥1 g/day) |
893 |
29 |
(3.3) |
1.3 (0.9-1.9) |
1.2
(0.8-1.8) |
Low use trajectory |
992 |
30 |
(3.0) |
1.2 (0.8-1.8) |
1.2
(0.8-1.7) |
High use trajectory |
123 |
3 |
(2.4) |
1.0 (0.3-3.1) |
N/A |
Calcium-based antacids in GW 0-16 |
|
|
|
|
|
No use |
8,276 |
206 |
(2.5) |
Reference |
Reference |
Any use |
728 |
26 |
(3.6) |
1.4 (1.0-2.1) |
1.3
(0.9-1.9) |
Low dose (<1 g/day) |
314 |
16 |
(5.1) |
2.0 (1.2-3.4) |
1.8
(1.1-2.9) |
High dose (≥1 g/day) |
235 |
7 |
(3.0) |
1.2 (0.6-2.5) |
1.1
(0.5-2.4) |
Calcium-based antacids in GW 17-33 |
|
|
|
|
|
No use |
7,201 |
185 |
(2.6) |
Reference |
Reference |
Any use |
1,604 |
45 |
(2.8) |
1.1 (0.8-1.5) |
1.0
(0.7-1.4) |
Low dose (<1 g/day) |
847 |
20 |
(2.4) |
0.9 (0.6-1.4) |
0.9
(0.6-1.4) |
High dose (≥1 g/day) |
690 |
22 |
(3.2) |
1.2 (0.8-1.9) |
1.2
(0.8-1.8) |
Proton pump inhibitors in GW 0-33 |
|
|
|
|
|
No use |
8,502 |
217 |
(2.6) |
Reference |
Reference |
Any use |
332 |
14 |
(4.2) |
1.7 (1.0-2.8) |
1.4
(0.8-2.4) |
Low dose (≤1 DDD/day) |
242 |
11 |
(4.6) |
1.8 (1.0-3.2) |
1.5
(0.8-2.8) |
High dose (>1 DDD per day) |
85 |
3 |
(3.5) |
1.4 (0.5-4.2) |
N/A |
Proton pump inhibitors in GW 0-16 |
|
|
|
|
|
No use |
8,868 |
229 |
(2.6) |
Reference |
Reference |
Any use |
170 |
6 |
(3.5) |
1.4 (0.6-3.0) |
1.1 (0.5-2.6) |
Low dose (≤1 DDD/day) |
91 |
4 |
(4.4) |
1.7 (0.6-4.5) |
N/A |
High dose (>1 DDD/day) |
53 |
0 |
(0.0) |
N/A |
N/A |
Proton pump inhibitors in GW 17-33 |
|
|
|
|
|
No use |
8,544 |
217 |
(2.5) |
Reference |
Reference |
Any use |
289 |
14 |
(4.8) |
1.9 (1.1-3.2) |
1.6
(1.0-2.8) |
Low dose (≤1 DDD/day) |
210 |
9 |
(4.3) |
1.7 (0.9-3.2) |
1.5
(0.8-3.0) |
High dose (>1 DDD/day) |
57 |
3 |
(5.3) |
2.1 (0.7-6.3) |
N/A |